
The global Pathology Testing Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Currently, precision medicine has become an important trend in the medical industry. Pathological testing is a key step in achieving precision medicine. Through accurate pathological diagnosis, doctors can develop personalized treatment plans for patients and improve treatment effects. With the advancement of science and technology, pathological detection technology is also constantly developing. For example, the application of new technologies such as molecular pathology testing and gene sequencing has made pathological testing more accurate and efficient. In the future, with the further application of technologies such as artificial intelligence and big data, the efficiency and accuracy of pathological detection are expected to be further improved.
This report aims to provide a comprehensive presentation of the global market for Pathology Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pathology Testing Services.
Report Scope
The Pathology Testing Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pathology Testing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pathology Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quest Diagnostics
BML
Dianon
Pathology Laboratories
Experimental Pathology Laboratories,Inc.
PathAI
Randox Health
ACE Laboratory Services
Clinical Labs
SYNLAB UK & Ireland
Metropolis Healthcare Ltd.
Acupath Laboratories
Clinipath (Malaysia) Sdn Bhd
QML Pathology Vetnostics
Confluence Health
MPS Ltd
Quest Diagnostics Newsroom
Targos
Sonic Healthcare Limited
Segment by Type
Histopathological Examination
Cytopathological Examination
Molecular Pathology Examination
Segment by Application
Hospital
Clinic
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pathology Testing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pathology Testing Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Histopathological Examination
1.2.3 Cytopathological Examination
1.2.4 Molecular Pathology Examination
1.3 Market by Application
1.3.1 Global Pathology Testing Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pathology Testing Services Market Perspective (2019-2030)
2.2 Pathology Testing Services Growth Trends by Region
2.2.1 Global Pathology Testing Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pathology Testing Services Historic Market Size by Region (2019-2024)
2.2.3 Pathology Testing Services Forecasted Market Size by Region (2025-2030)
2.3 Pathology Testing Services Market Dynamics
2.3.1 Pathology Testing Services Industry Trends
2.3.2 Pathology Testing Services Market Drivers
2.3.3 Pathology Testing Services Market Challenges
2.3.4 Pathology Testing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pathology Testing Services Players by Revenue
3.1.1 Global Top Pathology Testing Services Players by Revenue (2019-2024)
3.1.2 Global Pathology Testing Services Revenue Market Share by Players (2019-2024)
3.2 Global Pathology Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pathology Testing Services Revenue
3.4 Global Pathology Testing Services Market Concentration Ratio
3.4.1 Global Pathology Testing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pathology Testing Services Revenue in 2023
3.5 Pathology Testing Services Key Players Head office and Area Served
3.6 Key Players Pathology Testing Services Product Solution and Service
3.7 Date of Enter into Pathology Testing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pathology Testing Services Breakdown Data by Type
4.1 Global Pathology Testing Services Historic Market Size by Type (2019-2024)
4.2 Global Pathology Testing Services Forecasted Market Size by Type (2025-2030)
5 Pathology Testing Services Breakdown Data by Application
5.1 Global Pathology Testing Services Historic Market Size by Application (2019-2024)
5.2 Global Pathology Testing Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pathology Testing Services Market Size (2019-2030)
6.2 North America Pathology Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pathology Testing Services Market Size by Country (2019-2024)
6.4 North America Pathology Testing Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pathology Testing Services Market Size (2019-2030)
7.2 Europe Pathology Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pathology Testing Services Market Size by Country (2019-2024)
7.4 Europe Pathology Testing Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pathology Testing Services Market Size (2019-2030)
8.2 Asia-Pacific Pathology Testing Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pathology Testing Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Pathology Testing Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pathology Testing Services Market Size (2019-2030)
9.2 Latin America Pathology Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pathology Testing Services Market Size by Country (2019-2024)
9.4 Latin America Pathology Testing Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pathology Testing Services Market Size (2019-2030)
10.2 Middle East & Africa Pathology Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pathology Testing Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Pathology Testing Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Detail
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Pathology Testing Services Introduction
11.1.4 Quest Diagnostics Revenue in Pathology Testing Services Business (2019-2024)
11.1.5 Quest Diagnostics Recent Development
11.2 BML
11.2.1 BML Company Detail
11.2.2 BML Business Overview
11.2.3 BML Pathology Testing Services Introduction
11.2.4 BML Revenue in Pathology Testing Services Business (2019-2024)
11.2.5 BML Recent Development
11.3 Dianon
11.3.1 Dianon Company Detail
11.3.2 Dianon Business Overview
11.3.3 Dianon Pathology Testing Services Introduction
11.3.4 Dianon Revenue in Pathology Testing Services Business (2019-2024)
11.3.5 Dianon Recent Development
11.4 Pathology Laboratories
11.4.1 Pathology Laboratories Company Detail
11.4.2 Pathology Laboratories Business Overview
11.4.3 Pathology Laboratories Pathology Testing Services Introduction
11.4.4 Pathology Laboratories Revenue in Pathology Testing Services Business (2019-2024)
11.4.5 Pathology Laboratories Recent Development
11.5 Experimental Pathology Laboratories,Inc.
11.5.1 Experimental Pathology Laboratories,Inc. Company Detail
11.5.2 Experimental Pathology Laboratories,Inc. Business Overview
11.5.3 Experimental Pathology Laboratories,Inc. Pathology Testing Services Introduction
11.5.4 Experimental Pathology Laboratories,Inc. Revenue in Pathology Testing Services Business (2019-2024)
11.5.5 Experimental Pathology Laboratories,Inc. Recent Development
11.6 PathAI
11.6.1 PathAI Company Detail
11.6.2 PathAI Business Overview
11.6.3 PathAI Pathology Testing Services Introduction
11.6.4 PathAI Revenue in Pathology Testing Services Business (2019-2024)
11.6.5 PathAI Recent Development
11.7 Randox Health
11.7.1 Randox Health Company Detail
11.7.2 Randox Health Business Overview
11.7.3 Randox Health Pathology Testing Services Introduction
11.7.4 Randox Health Revenue in Pathology Testing Services Business (2019-2024)
11.7.5 Randox Health Recent Development
11.8 ACE Laboratory Services
11.8.1 ACE Laboratory Services Company Detail
11.8.2 ACE Laboratory Services Business Overview
11.8.3 ACE Laboratory Services Pathology Testing Services Introduction
11.8.4 ACE Laboratory Services Revenue in Pathology Testing Services Business (2019-2024)
11.8.5 ACE Laboratory Services Recent Development
11.9 Clinical Labs
11.9.1 Clinical Labs Company Detail
11.9.2 Clinical Labs Business Overview
11.9.3 Clinical Labs Pathology Testing Services Introduction
11.9.4 Clinical Labs Revenue in Pathology Testing Services Business (2019-2024)
11.9.5 Clinical Labs Recent Development
11.10 SYNLAB UK & Ireland
11.10.1 SYNLAB UK & Ireland Company Detail
11.10.2 SYNLAB UK & Ireland Business Overview
11.10.3 SYNLAB UK & Ireland Pathology Testing Services Introduction
11.10.4 SYNLAB UK & Ireland Revenue in Pathology Testing Services Business (2019-2024)
11.10.5 SYNLAB UK & Ireland Recent Development
11.11 Metropolis Healthcare Ltd.
11.11.1 Metropolis Healthcare Ltd. Company Detail
11.11.2 Metropolis Healthcare Ltd. Business Overview
11.11.3 Metropolis Healthcare Ltd. Pathology Testing Services Introduction
11.11.4 Metropolis Healthcare Ltd. Revenue in Pathology Testing Services Business (2019-2024)
11.11.5 Metropolis Healthcare Ltd. Recent Development
11.12 Acupath Laboratories
11.12.1 Acupath Laboratories Company Detail
11.12.2 Acupath Laboratories Business Overview
11.12.3 Acupath Laboratories Pathology Testing Services Introduction
11.12.4 Acupath Laboratories Revenue in Pathology Testing Services Business (2019-2024)
11.12.5 Acupath Laboratories Recent Development
11.13 Clinipath (Malaysia) Sdn Bhd
11.13.1 Clinipath (Malaysia) Sdn Bhd Company Detail
11.13.2 Clinipath (Malaysia) Sdn Bhd Business Overview
11.13.3 Clinipath (Malaysia) Sdn Bhd Pathology Testing Services Introduction
11.13.4 Clinipath (Malaysia) Sdn Bhd Revenue in Pathology Testing Services Business (2019-2024)
11.13.5 Clinipath (Malaysia) Sdn Bhd Recent Development
11.14 QML Pathology Vetnostics
11.14.1 QML Pathology Vetnostics Company Detail
11.14.2 QML Pathology Vetnostics Business Overview
11.14.3 QML Pathology Vetnostics Pathology Testing Services Introduction
11.14.4 QML Pathology Vetnostics Revenue in Pathology Testing Services Business (2019-2024)
11.14.5 QML Pathology Vetnostics Recent Development
11.15 Confluence Health
11.15.1 Confluence Health Company Detail
11.15.2 Confluence Health Business Overview
11.15.3 Confluence Health Pathology Testing Services Introduction
11.15.4 Confluence Health Revenue in Pathology Testing Services Business (2019-2024)
11.15.5 Confluence Health Recent Development
11.16 MPS Ltd
11.16.1 MPS Ltd Company Detail
11.16.2 MPS Ltd Business Overview
11.16.3 MPS Ltd Pathology Testing Services Introduction
11.16.4 MPS Ltd Revenue in Pathology Testing Services Business (2019-2024)
11.16.5 MPS Ltd Recent Development
11.17 Quest Diagnostics Newsroom
11.17.1 Quest Diagnostics Newsroom Company Detail
11.17.2 Quest Diagnostics Newsroom Business Overview
11.17.3 Quest Diagnostics Newsroom Pathology Testing Services Introduction
11.17.4 Quest Diagnostics Newsroom Revenue in Pathology Testing Services Business (2019-2024)
11.17.5 Quest Diagnostics Newsroom Recent Development
11.18 Targos
11.18.1 Targos Company Detail
11.18.2 Targos Business Overview
11.18.3 Targos Pathology Testing Services Introduction
11.18.4 Targos Revenue in Pathology Testing Services Business (2019-2024)
11.18.5 Targos Recent Development
11.19 Sonic Healthcare Limited
11.19.1 Sonic Healthcare Limited Company Detail
11.19.2 Sonic Healthcare Limited Business Overview
11.19.3 Sonic Healthcare Limited Pathology Testing Services Introduction
11.19.4 Sonic Healthcare Limited Revenue in Pathology Testing Services Business (2019-2024)
11.19.5 Sonic Healthcare Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Quest Diagnostics
BML
Dianon
Pathology Laboratories
Experimental Pathology Laboratories,Inc.
PathAI
Randox Health
ACE Laboratory Services
Clinical Labs
SYNLAB UK & Ireland
Metropolis Healthcare Ltd.
Acupath Laboratories
Clinipath (Malaysia) Sdn Bhd
QML Pathology Vetnostics
Confluence Health
MPS Ltd
Quest Diagnostics Newsroom
Targos
Sonic Healthcare Limited
Ìý
Ìý
*If Applicable.
